These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8391966)

  • 1. Pharmacokinetic properties of the trypanocidal drug melarsoprol.
    Burri C; Baltz T; Giroud C; Doua F; Welker HA; Brun R
    Chemotherapy; 1993; 39(4):225-34. PubMed ID: 8391966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
    Burri C; Brun R
    Trop Med Parasitol; 1992 Dec; 43(4):223-5. PubMed ID: 1293724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
    Miezan TW; Dje NN; Doua F; Boa F
    Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment.
    Burri C; Keiser J
    Trop Med Int Health; 2001 May; 6(5):412-20. PubMed ID: 11348536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
    Burri C; Onyango JD; Auma JE; Burudi EM; Brun R
    Acta Trop; 1994 Oct; 58(1):35-49. PubMed ID: 7863853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 12. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
    Maes L; Vanderveken M; Hamers R; Doua F; Cattand P
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):219-31. PubMed ID: 3223784
    [No Abstract]   [Full Text] [Related]  

  • 13. Human trypanosomiasis in the Ivory Coast: therapy and problems.
    Doua F; Yapo FB
    Acta Trop; 1993 Sep; 54(3-4):163-8. PubMed ID: 7902655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized.
    Bronner U; Brun R; Doua F; Ericsson O; Burri C; Keiser J; Miézan TW; Boa YF; Rombo L; Gustafsson LL
    Trop Med Int Health; 1998 Nov; 3(11):913-7. PubMed ID: 9855405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy.
    Ericsson O; Schweda EK; Bronner U; Rombo L; Fridén M; Gustafsson LL
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):243-51. PubMed ID: 9106049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative application of melarsoprol for treatment of T. B. gambiense sleeping sickness. Preliminary results.
    Burri C; Blum J; Brun R
    Ann Soc Belg Med Trop; 1995 Mar; 75(1):65-71. PubMed ID: 7794064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
    Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R
    Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis.
    Harrison SM; Harris RW; Bales JD
    Am J Trop Med Hyg; 1997 Jun; 56(6):632-6. PubMed ID: 9230794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.